Clinical trial for Chronic Kidney Diseases
Official title Telemonitoring of Hypertensive Patients With Chronic Kidney Disease
ClinicalTrials.gov ID: NCT04098354
What this study is testing
- What it's testing
- The study will see if adding a case manager to home blood‑pressure telemonitoring lowers systolic blood pressure after 12 months. It will also look at cost, acceptability, and safety.
- Who it's for
- Adults with chronic kidney disease and high blood pressure who live in remote areas of Northern Alberta and have a smartphone and internet access.
- What's involved
- Participants will measure their blood pressure four times a day for one week and send the readings via a smartphone app. One group will have a case manager adjust their medicines; the other group will just share the readings with their regular doctor. This 1‑week monitoring will be repeated every three months for a year.
- Time commitment
- The trial lasts 12 months, with weekly blood‑pressure monitoring each quarter and remote follow‑up visits.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age equal to and more than 18 years with documented diagnosis of established CKD (not on dialysis with eGFR \ 1 g/day)
- Remote dwelling patients in the Peace River region of Alberta, Canada
- Patients known with hypertension (physician diagnosed / self reported and currently taking antihypertensive medications)
- Owning a smartphone (iOS or Android) with access to wireless internet connection.
- Proficiency in English language (both verbal and written); and ability and willingness to provide informed consent for participation.
You likely can't join if
- Patients with hypertensive urgency or emergency identified during the training period (immediate consultation will be initiated with the patient's...
- Patients with stage 5 CKD (eGFR ≤ 15 ml/min/1.73m2) or patients receiving kidney replacement therapy
- Heart failure with reduced ejection fraction
- Presence of any terminal illness (life expectancy \< 1 year)
- Participation in any ongoing clinical drug trial
- Pregnancy, lactation / breastfeeding
See the full eligibility criteria
- Age equal to and more than 18 years with documented diagnosis of established CKD (not on dialysis with eGFR \ 1 g/day)
- Remote dwelling patients in the Peace River region of Alberta, Canada
- Patients known with hypertension (physician diagnosed / self reported and currently taking antihypertensive medications)
- Owning a smartphone (iOS or Android) with access to wireless internet connection.
- Proficiency in English language (both verbal and written); and ability and willingness to provide informed consent for participation.
- Ability and willingness to use the HBPT device (≥ 80% recordings sent in the training period)
- Patients with hypertensive urgency or emergency identified during the training period (immediate consultation will be initiated with the patient's PCP or with a hypertension specialist)
- Patients with stage 5 CKD (eGFR ≤ 15 ml/min/1.73m2) or patients receiving kidney replacement therapy
- Heart failure with reduced ejection fraction
- Presence of any terminal illness (life expectancy \< 1 year)
- Participation in any ongoing clinical drug trial
- Pregnancy, lactation / breastfeeding
- Planning to relocate out of the Peace River region or residence in an area without mobile phone coverage.
The study team makes the final eligibility decision.
Where it is enrolling
- Edmonton, Albert, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Edmonton, Albert, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.